PURPLE BIOTECH LTD. — Major Shareholding Notification 2021

Feb 16, 2021

SC 13G/A 1 tm216476d43_sc13ga.htm SCHEDULE 13G/A

CUSIP No: 74638P109

Field: Rule-Page

Field: /Rule-Page

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Field: Rule-Page

Field: /Rule-Page

SCHEDULE 13G

(Rule 13d-102)

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

TO § 240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED

PURSUANT TO § 240.13d-2.

(Amendment No. 1)*

Purple Biotech Ltd. (formerly Kitov Pharma Ltd.)

(Name of Issuer)

Ordinary Shares, no par value

(Title of Class of Securities)

74638P109 (CUSIP Number)

December 31, 2020

(Date of Event Which Requires Filing of this statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

¨ Rule 13d-1(b)

x Rule 13d-1(c)

¨ Rule 13d-1(d)

Field: Rule-Page

Field: /Rule-Page

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

Field: Rule-Page

Field: /Rule-Page

Field: Page; Sequence: 1; Options: NewSection

Field: /Page

CUSIP No: 74638P109

(1)	NAMES OF REPORTING PERSONS
	CVI Investments, Inc.
(2)	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
	(SEE INSTRUCTIONS)
	(a) ¨
	(b) ¨
(3)	SEC USE ONLY
(4)	CITIZENSHIP OR PLACE OF ORGANIZATION
	Cayman Islands

NUMBER OF	(5)	SOLE VOTING POWER
SHARES		0
BENEFICIALLY	(6)	SHARED VOTING POWER **
OWNED BY		1,348,889
EACH
	(7)	SOLE DISPOSITIVE POWER
REPORTING
		0
PERSON WITH
	(8)	SHARED DISPOSITIVE POWER **
		1,348,889

(9)	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
	1,348,889
(10)	CHECK BOX IF THE AGGREGATE AMOUNT
	IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
	¨
(11)	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
	0.8%
(12)	TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
	CO

** Heights Capital Management, Inc. is the investment manager to CVI Investments, Inc. and as such may exercise voting and dispositive power over these shares.

Field: Page; Sequence: 2

Field: /Page

CUSIP No: 74638P109

(1)	NAMES OF REPORTING PERSONS
	Heights Capital Management, Inc.
(2)	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
	(SEE INSTRUCTIONS)
	(a) ¨
	(b) ¨
(3)	SEC USE ONLY
(4)	CITIZENSHIP OR PLACE OF ORGANIZATION
	Delaware

NUMBER OF	(5)	SOLE VOTING POWER
SHARES		0
BENEFICIALLY	(6)	SHARED VOTING POWER **
OWNED BY		1,348,889
EACH
	(7)	SOLE DISPOSITIVE POWER
REPORTING
		0
PERSON WITH
	(8)	SHARED DISPOSITIVE POWER **
		1,348,889

(9)	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
	1,348,889
(10)	CHECK BOX IF THE AGGREGATE AMOUNT
	IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
	¨
(11)	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
	0.8%
(12)	TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
	CO

** Heights Capital Management, Inc. is the investment manager to CVI Investments, Inc. and as such may exercise voting and dispositive power over these shares.

Field: Page; Sequence: 3

Field: /Page

CUSIP No: 74638P109

Item 1.

(a) Name of Issuer

Purple Biotech Ltd. (formerly Kitov Pharma Ltd.)(the “Company”)

(b) Address of Issuer’s Principal Executive Offices

4 Oppenheimer Street, Science Park, Rehovot 7670104, Israel

Item 2(a). Name of Person Filing

This statement is filed by the entities listed below, who are collectively referred to herein as “Reporting Persons,” with respect to the ordinary shares of the Company, no par value (the “Shares”).

(i) CVI Investments, Inc.

(ii) Heights Capital Management, Inc.

Item 2(b). Address of Principal Business Office or, if none, Residence

The address of the principal business office of CVI Investments, Inc. is:

P.O. Box 309GT

Ugland House

South Church Street

George Town

Grand Cayman

KY1-1104

Cayman Islands

The address of the principal business office of Heights Capital Management, Inc. is:

101 California Street, Suite 3250

San Francisco, California 94111

Item 2(c). Citizenship

Citizenship is set forth in Row 4 of the cover page for each Reporting Person hereto and is incorporated herein by reference for each such Reporting Person.

Item 2(d) Title of Class of Securities

Ordinary shares, no par value

Item 2(e) CUSIP Number

74638P109 The CUSIP Number applies to the American Depositary Shares, each of which represents one (1) Share.

Field: Page; Sequence: 4

Field: /Page

CUSIP No: 74638P109

Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

| (a) | ¨ | Broker
or dealer registered under Section 15 of the Act (15 U.S.C. 78o). |
| --- | --- | --- |
| (b) | ¨ | Bank
as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c). |
| (c) | ¨ | Insurance
company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c). |
| (d) | ¨ | Investment
company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). |
| (e) | ¨ | An
investment adviser in accordance with §240.13d-1(b)(1)(ii)(E); |
| (f) | ¨ | An
employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F); |
| (g) | ¨ | A
parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G); |
| (h) | ¨ | A
savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); |
| (i) | ¨ | A
church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company
Act of 1940 (15 U.S.C. 80a-3); |
| (j) | ¨ | A non-U.S.
institution in accordance with §240.13d-1(b)(1)(ii)(J); |
| (k) | ¨ | Group,
in accordance with Rule 13d-1(b)(1)(ii)(K). |

If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution: ____

ITEM 4. Ownership

Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

The information required by Items 4(a) – (c) is set forth in Rows 5 – 11 of the cover page for each Reporting Person hereto and is incorporated herein by reference for each such Reporting Person.

The number of Shares reported as beneficially owned consists of Shares (represented by American Depositary Shares) issuable upon the exercise of warrants to purchase American Depositary Shares.

The Company’s Proxy Statement, filed on October 22, 2020, indicates there were 172,105,742 Shares outstanding as of October 20, 2020.

Heights Capital Management, Inc., which serves as the investment manager to CVI Investments, Inc., may be deemed to be the beneficial owner of all Shares owned by CVI Investments, Inc. Each of the Reporting Persons hereby disclaims any beneficial ownership of any such Shares, except for their pecuniary interest therein.

Field: Page; Sequence: 5

Field: /Page

CUSIP No: 74638P109

ITEM 5. Ownership of Five Percent or Less of a Class

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: [x]

ITEM 6. Ownership of More than Five Percent on Behalf of Another Person

Not applicable.

ITEM 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person

Not applicable.

ITEM 8. Identification and Classification of Members of the Group

Not applicable.

ITEM 9. Notice of Dissolution of Group

Not applicable.

ITEM 10. Certification

By signing below each of the undersigned certifies that, to the best of its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

Field: Page; Sequence: 6

Field: /Page

CUSIP No: 74638P109

SIGNATURES

After reasonable inquiry and to the best of its knowledge and belief, each of the undersigned certifies that the information with respect to it set forth in this statement is true, complete, and correct.

Dated: February 10, 2021 — CVI INVESTMENTS, INC.	HEIGHTS CAPITAL MANAGEMENT, INC.
By: Heights Capital Management, Inc.	By:	/s/ Brian Sopinsky
pursuant to a Limited
Power of	Name: Brian Sopinsky
Attorney, a copy of which was	Title: Secretary
previously filed
By:	/s/ Brian Sopinsky
Name: Brian Sopinsky
Title: Secretary

Field: Page; Sequence: 7

Field: /Page

CUSIP No: 74638P109

EXHIBIT INDEX

EXHIBIT	DESCRIPTION
I	Limited Power of Attorney*
II	Joint Filing Agreement*

*Previously filed

Field: Page; Sequence: 8; Options: Last

Field: /Page